<DOC>
	<DOC>NCT00969163</DOC>
	<brief_summary>Postmenopausal women will receive testosterone gel or matching placebo gel daily. Sebum excretion rates will be measured before and after 6 weeks of treatment.</brief_summary>
	<brief_title>A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).</brief_title>
	<detailed_description />
	<mesh_term>Virilism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Subject is at least 3 years postmenopausal Subject is in good general health Subject is willing to avoid excess alcohol or strenuous physical activity during the study Subject has donated a unit of blood or has taken an investigational drug in another clinical trial in the last 4 weeks Subject is a regular user of any illicit drugs Subject drinks excessive amounts of coffee, tea or cola Subject has used an estrogen or progestogens hormone replacement therapy in the past 6 months Subject has a history of cancer Subject has acne</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Biomarkers of Skin Androgenization</keyword>
</DOC>